COVID-19 in ocrelizumab-treated people with multiple sclerosis
Sign Up to like & getrecommendations! Published in 2020 at "Multiple Sclerosis and Related Disorders"
DOI: 10.1016/j.msard.2020.102725
Abstract: Background : There are limited data on the impact of coronavirus disease (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) on people with multiple sclerosis (MS). Objective : To better understand SARS-CoV-2… read more here.
Keywords: covid; treated people; ocrelizumab treated; roche genentech ... See more keywords
ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early stage triple negative breast cancer
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz240.112
Abstract: Abstract Background Early stage triple negative breast cancer (TNBC) is associated with a high risk of distant relapse. Because TNBC does not currently have specific targeted agents approved for use in the early setting it… read more here.
Keywords: research; research grant; grant funding; roche genentech ... See more keywords